Publication | Closed Access

Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)

Oral Masitinib MesilateSurgical OncologyGastrointestinal OncologyMedicineGastroenterologyGastrointestinal Stromal TumorsPathologyPhase Ii StudyImatinib-naïve PatientsCancer TreatmentOncologyRadiation OncologyCancer Research